Research And Development
Health
Biotechnology

Midatech Pharma

$0.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.005 (-1.31%) Today
-$0.007 (-1.86%) After Hours

Why Robinhood?

You can buy or sell MTP and other stocks, options, ETFs, and crypto commission-free!

About

Midatech Pharma Plc commercializes oncology treatments and cancer supportive care products through its U.S. commercial organization, Midatech Pharma US. The company engages in the development of pharmaceutical products utilizing its nanomedicine and sustained release technologies. Read More It operates through Pipeline Research & Development and Commercial segments. The Pipeline Research & Development segment seeks to develop products using nanomedicine and sustained release technology platforms. The Commercial segment distributes and sells commercial products. The company was founded on September 12, 2014 and is headquartered in Abingdon, the United Kingdom.

Employees
Headquarters
Abingdon, Oxfordshire
Founded
2014
Market Cap
11.84M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
693.34K
High Today
$0.41
Low Today
$0.3501
Open Price
$0.40
Volume
188.82K
52 Week High
$1.80
52 Week Low
$0.1031

Collections

Research And Development
Health
Biotechnology
Pharmaceutical
Cancer Prevention

News

MarketBeatFeb 27

Stock Price, News, & Analysis for Midatech Pharma

Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom.

1,446
Seeking AlphaFeb 27

Midatech adds to CMS investment-stoked rally, up 49%

Nano cap Midatech Pharma (MTP +48.9% ) is up on a healthy 32x surge in volume. Shares have rallied six-fold in two days after the it announced shareholders' support for its out-license deal with China Medical Systems Holdings group (CMS) under which the latter has the rights to develop and commercialize its pipeline in China and certain Asian countries (except Japan and South Korea). Under the terms of the agreement, MTP will receive milestone payments (subject to conditions) and royalties on net sales. C...

3,358
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.